Preface |
|
ix | |
Acknowledgments |
|
xi | |
Author |
|
xiii | |
1 Introduction |
|
1 | |
|
|
1 | |
|
1.2 Statistical Methods in Diagnostic Medicine |
|
|
1 | |
|
|
2 | |
|
1.4 Datasets for the Book |
|
|
4 | |
|
|
4 | |
|
|
5 | |
2 Diagnostic Medicine |
|
7 | |
|
|
7 | |
|
|
7 | |
|
2.3 Activities in Diagnostic Imaging |
|
|
11 | |
|
2.4 Accuracy and Agreement |
|
|
12 | |
|
2.5 Developmental Trials for Imaging |
|
|
14 | |
|
2.6 Protocol Review and Clinical Trials |
|
|
15 | |
|
|
16 | |
|
2.6.2 Phase I, II, and III Clinical Designs |
|
|
16 | |
|
|
18 | |
|
|
18 | |
3 Other Diagnostic Procedures |
|
21 | |
|
|
21 | |
|
3.2 Sentinel Lymph Node Biopsy for Melanoma |
|
|
21 | |
|
3.3 Tumor Depth to Diagnose Metastatic Melanoma |
|
|
22 | |
|
3.4 Biopsy for Nonsmall Cell Lung Cancer |
|
|
23 | |
|
3.5 Coronary Artery Disease |
|
|
24 | |
|
|
24 | |
4 Bayesian Statistics |
|
27 | |
|
|
27 | |
|
|
28 | |
|
|
29 | |
|
4.4 Posterior Information |
|
|
33 | |
|
|
36 | |
|
|
36 | |
|
|
36 | |
|
|
38 | |
|
|
38 | |
|
4.5.3.2 Binomial Example of Testing |
|
|
39 | |
|
4.5.3.3 Comparing Two Binomial Populations |
|
|
40 | |
|
4.5.3.4 Sharp Null Hypothesis for the Normal Mean |
|
|
41 | |
|
|
41 | |
|
|
41 | |
|
4.6.2 A One-Sample Binomial for Response |
|
|
42 | |
|
4.6.3 A One-Sample Binomial with Prior Information |
|
|
44 | |
|
4.6.4 Comparing Two Binomial Populations |
|
|
45 | |
|
|
45 | |
|
|
45 | |
|
4.7.2 Direct Methods of Computation |
|
|
46 | |
|
|
49 | |
|
|
49 | |
|
4.7.3.2 Common Mean of Normal Populations |
|
|
50 | |
|
4.7.3.3 MCMC Sampling with WinBUGS® |
|
|
53 | |
|
|
56 | |
|
|
57 | |
5 Bayesian Methods for Diagnostic Accuracy |
|
59 | |
|
|
59 | |
|
|
60 | |
|
|
60 | |
|
|
60 | |
|
|
61 | |
|
5.2.4 Patient and Reader Selection |
|
|
61 | |
|
|
62 | |
|
|
63 | |
|
5.2.7 Statistical Design and Analysis |
|
|
63 | |
|
|
64 | |
|
5.3 Bayesian Methods for Test Accuracy: Binary and Ordinal Data |
|
|
65 | |
|
|
65 | |
|
5.3.2 Classification Probabilities |
|
|
65 | |
|
|
68 | |
|
5.3.4 Diagnostic Likelihood Ratios |
|
|
69 | |
|
|
69 | |
|
5.4 Bayesian Methods for Test Accuracy: Quantitative Variables |
|
|
73 | |
|
|
73 | |
|
5.4.2 The Spokane Heart Study |
|
|
73 | |
|
|
74 | |
|
5.4.4 Definition of the ROC Curve |
|
|
77 | |
|
5.4.5 Choice of Optimal Threshold Value |
|
|
78 | |
|
5.5 Clustered Data: Detection and Localization |
|
|
79 | |
|
|
79 | |
|
5.5.2 Bayesian ROC Curve for Clustered Information |
|
|
80 | |
|
5.5.3 Clustered Data in Mammography |
|
|
82 | |
|
5.6 Comparing Accuracy between Modalities |
|
|
84 | |
|
5.7 Sample Size Determination |
|
|
87 | |
|
|
87 | |
|
5.7.2 Discrete Diagnostic Scores |
|
|
88 | |
|
|
88 | |
|
5.7.2.2 Multinomial Outcomes |
|
|
91 | |
|
5.7.3 Sample Sizes: Continuous Diagnostic Scores |
|
|
92 | |
|
|
92 | |
|
|
95 | |
|
|
97 | |
|
|
99 | |
6 Regression and Test Accuracy |
|
101 | |
|
|
101 | |
|
|
102 | |
|
|
102 | |
|
|
102 | |
|
|
103 | |
|
6.2.4 Diagnostic Likelihood Ratio |
|
|
105 | |
|
6.3 ROC Area and Patient Covariates |
|
|
107 | |
|
|
107 | |
|
6.3.2 ROC Curve as Response to Therapy |
|
|
108 | |
|
6.3.3 Diagnosing Prostate Cancer |
|
|
110 | |
|
|
111 | |
|
|
111 | |
7 Agreement |
|
113 | |
|
|
113 | |
|
7.2 Agreement for Discrete Ratings |
|
|
114 | |
|
|
114 | |
|
7.2.2 Other Indices of Agreement |
|
|
116 | |
|
7.2.3 A Bayesian Version of McNemar |
|
|
117 | |
|
7.2.4 Comparing Two Kappa Parameters |
|
|
117 | |
|
7.2.5 Kappa and Stratification |
|
|
119 | |
|
7.2.6 Multiple Categories and Two Readers |
|
|
120 | |
|
7.2.7 Multiple Categories |
|
|
122 | |
|
7.2.8 Agreement and Covariate Information |
|
|
123 | |
|
7.3 Agreement for a Continuous Response |
|
|
126 | |
|
|
126 | |
|
7.3.2 Intra-Class Correlation Coefficient |
|
|
127 | |
|
7.3.2.1 One-Way Random Model |
|
|
127 | |
|
7.3.2.2 Two-Way Random Model |
|
|
131 | |
|
7.3.3 Regression and Agreement |
|
|
132 | |
|
7.4 Combining Reader Information |
|
|
134 | |
|
|
136 | |
|
|
139 | |
8 Diagnostic Imaging and Clinical Trials |
|
141 | |
|
|
141 | |
|
|
142 | |
|
|
142 | |
|
|
142 | |
|
|
143 | |
|
|
145 | |
|
|
145 | |
|
8.4 Guidelines for Tumor Response |
|
|
146 | |
|
8.5 Bayesian Sequential Stopping Rules |
|
|
148 | |
|
8.6 Software for Clinical Trials |
|
|
152 | |
|
8.6.1 CRM Simulator for Phase I Trials |
|
|
153 | |
|
8.6.2 Multc Lean for Phase II Trials |
|
|
153 | |
|
|
154 | |
|
8.7.1 Phase I Trial for Renal Cell Carcinoma |
|
|
154 | |
|
8.7.2 An Ideal Phase II Trial |
|
|
156 | |
|
8.7.3 Phase II Trial for Advanced Melanoma |
|
|
158 | |
|
|
162 | |
|
|
163 | |
9 Other Topics |
|
165 | |
|
|
165 | |
|
9.2 Imperfect Diagnostic Test Procedures |
|
|
166 | |
|
9.2.1 Extreme Verification Bias |
|
|
166 | |
|
|
170 | |
|
9.2.3 Estimating Test Accuracy with No Gold Standard |
|
|
173 | |
|
9.3 Test Accuracy and Survival Analysis |
|
|
178 | |
|
9.4 ROC Curves with a Non-Binary Gold Standard |
|
|
180 | |
|
9.5 Periodic Screening in Cancer |
|
|
182 | |
|
9.5.1 Inference for Sensitivity and Transition Probability |
|
|
182 | |
|
9.5.2 Bayesian Inference for Lead-Time |
|
|
186 | |
|
9.6 Decision Theory and Diagnostic Accuracy |
|
|
189 | |
|
|
192 | |
References |
|
193 | |
Index |
|
195 | |